Critter Controllers

Not All Animals Are The Cutest

Category: Entrepreneurs

30 May 2019

The Business and Management Team: Meet Lincolnshire Management  0

There is a private equity firm that is getting a lot of attention. Recently, Lincolnshire Management has been assisting business owners with producing their own portfolios. The portfolios help those in business realize what type of goals and objectives they are trying to reach. In some instances, they have a certain amount of time to work on their projects. They have to meet the deadlines before they lose a contract with another company. That can place a lot of stress on the leadership directors.

 

Lincolnshire Management assists with their clients with those goals along with working on their own company goals. For instance, Lincolnshire Management decided to sell a part of their company. They had first decided to invest into Holley Performance Products. As it turns out, Holley Performance Products are the largest manufacturer of automotive brands. These types of brands are stable for that particular business and industry. Although Lincolnshire Management sold Holley Performance Products, the company has still maintained its number one spot in the automotive industry. Lincolnshire Management has a great reputation for giving all business owners a chance to work with them.

 

Lincolnshire Management was founded in 1986 by Steven Kumble and Frank Wright. After years of working in the business and loan industry, the company was able to capitalize on making close to $2 billion dollars. The company produced many different types of private equity funds during the course of striving for the best. With 55 investments, the company has chosen to invest into Riddell, Prince Sports, and American Coach Lines. These investments have secured the company. As a result, the two founders decided to choose another CEO. Today, the company is ran by T.J. Maloney. As the CEO continues to recruit the best candidates for business transactions, Lincolnshire Management will still continue to invest and sell in the lane of business and equity. In reality, Lincolnshire Management has put in a tremendous amount of work in order to complete contracts or agreements.

 

Lately, the company managed to sell National Pens and rack in $218 million dollars in profit. National Pen is known for manufacturing writing instruments and selling those at bulk to other businesses. The New York based company will have other future investments take place. As long as the team that T.J. Maloney has place together stays together, there is no stopping this private equity company. In fact, Lincolnshire Management is becoming a household name to those who are in the business industry. With that in mind, there are plenty of negotiations that can take place because of Lincolnshire Management.

Read about the sale of National Pens in details here https://www.pehub.com/2017/01/lincolnshire-management-sells-national-pen-for-about-218-mln/.

 

04 May 2019

Marc Beer And His New Role Of Chairman Of The Board At LumeN XT  0

The Boston-based surgical device company LumeN XT announced at the beginning of April the addition of Marc Beer to the company’s team, with him taking on the role of LumeNXT’s Chairman of the Board. Beer brings to the table more than 25 years of experience in areas of development and commercialization in the field of pharmaceuticals, devices, biotechnology, and diagnostics.

 

About LumeN XT And Its Illumination Platform

 

LumeN XT is a private company, considered to be a pioneer when it comes to the use of intracavity LED (light emitting diode) illumination. The company focuses on the development of surgical illumination product line in order to help with surgeries that are minimally invasive. LumeNXT’s illumination platform is used as a heat reduction mechanism designed to provide various advantages, such as improved surgical precision, increased workflow efficiency and improved safety via enhanced visualization. Surgeons who are using targeted illumination have pointed out that the, when compared to traditional techniques, the technology enhances flexibility, precision, and visualization.

 

Taking On The Role Of Chairman of the Board

 

The seasoned pharmaceuticals executive talked about his new role of Chairman of the Board and about the company in general. Beer stated this pride in working with ELemeNT’s group of surgeon and engineers, describing them as being accomplished and dedicated. He also noted that they are responsible with advancing the field of surgical illumination by using LumeNXT’s technology towards safely performing surgeries. In addition, he believes that the importance of the company’s platform will increase once more surgeries will be performed featuring minimally invasive approaches.

 

Paul Rhyne, the co-founder of LumeN XT also talked about the new addition to the team, noting that Beer has had high levels of success in working with multiple startup companies, and that his experience is highly valued at LumeN XT.

 

About Marc Beer

 

Besides his new role of Chairman of the Board at LumeN XT, Marc Beer also dedicates time to his own company, Renovia, Inc., which he co-founded in August 2016. The company’s goal is to find and deliver digital therapeutic and diagnostic devices to women who suffer from pelvic floor disorders. Prior to LumeN XT and Renovia, Marc Beer worked for a number of companies within the biotechnology industry, making a name for himself and earning a reputation, with a career that spans over more than 25 years.

 

He worked for Minerva Neurosciences Inc. as the Founding Chairman, Erytech Pharma as a member of the Board of Directors, and was also part of Good Start Genetics, Inc. serving as Founding Chairman. In addition, Beer was the Founding CEO of ViaCell, from 2000 to 2007. Under his leadership, the company saw rapid growth, having over 300 employees, going public in 2005, before being ultimately acquired by PerkinElmer in 2007. Learn more: https://renoviainc.com/leadership/

05 Mar 2019

“Marc Beer succeeds once more in raising funds for women’s health through Series B round “  0

Starting a company in today’s competitive biotech industry deserves a high degree of skill to do research, financing and the approval for new therapies from the FDA, Food and Drug Administration. Renovia Inc. is one of the companies that started through the mentioned processes in August 2016 during its foundation by Marc Beer. The company that operates from Boston raised funds through Series A round and used the money to finance the technology of fighting pelvic floor disorder from another company. The problem faces over 230 million women worldwide, but Renovia continues to look for ways of helping the affected women. Its first product to get approval from FDA was Leva device in April 2018.

 

Marc Beer successfully organized the series B funding that took place on August 21, 2018, that raised $32.3 million in equity and $10 million in venture funds making a total of $42.3 million. According to the company’s management, the funds would go into diagnostic analysis and development of four more products on top of leva device. The company also intends to upgrade its leva pelvic health digital system through the funds and cater for clinical experiments, corporate development, and improvement of the production system and launching of products. New York’s Perceptive Advisers is one of the Renovia’s business partners that stood with Renovia. Ascension Ventures that work from Missouri participated in the process, and Marc Beer thanked the two among other health companies supporting such health initiatives.

 

Apart from boosting the treatment and diagnostic systems, Renovia Inc. plans to use some of the funding to promote the leva device. Leva device comes with a Bluetooth and an app for generating coaching schedules, and real-time visualization. The primary functions of the invention are to control the linear optimized moving patterns and to sort out the weak leva plate muscles. Besides, the company would come up with more wearable devices and other innovative diagnostic materials and clinical procedures. The millions of women suffering from pelvic floor disorders undergo painful sessions of urinary incontinence, frequent urination, pain pressure, and problems of emptying the whole bladder after urination and painful intercourse.

 

Marc Beer points out that the new digital platform would help the patients’ access to more data covering the new methods of treatment, basic knowledge, and the way of lowering treatment costs. Marc Beer has the expertise of 25 years in sales, development, biotechnology, and management having worked in recognized companies like Viacell and Abbott laboratories. In Viatell, Marc worked in the control of the company, and he oversaw the overall study of the human cells to come out with the desired cures. His idea of starting Renovia was to help the women access quality care through the latest technology at affordable prices through the Leva Pelvic Digital Health System. Learn more: https://www.bizjournals.com/boston/news/2018/08/21/ex-aegerion-chief-beer-raises-42m-for-womens.html